According to FUNDER website data,
62 mutual funds hold NIS 13.33 million in Brainsway shares
Funds that hold significant holdings in the stock – for the full list of holdings
The following is a change in the holdings of mutual funds in Brainsway shares according to FUNDER-MVF data
Brainsway (NASDAQ & TASE: BWAY), a world leader in advanced and non-invasive treatment for brain disorders, today reports partial preliminary results for the fourth quarter of 2020.
Preliminary financial results
• For the three months ended December 31, 2020, Brainsway reached quarterly record revenues in the range of $ 6.8 million to $ 7.1 million, representing an increase of 13.3% -18.3% compared to the previous quarter and an increase of 7.9% -12.7% compared to the fourth quarter of 2019 , And demonstrates strong recovery and acceleration in business while the operating environment continues to improve.
Revenues in 2020 ranged from $ 21.8 million to $ 22.1 million, representing a decrease of 4.3% -5.6% compared to the previous year, due to the effects of the corona virus.
• As of December 31, 2020, the installation base of Deep TMS systems stood at 629 systems after the addition of 36 systems during the fourth quarter, an increase of 18.7% compared to the 2019 results.
• As of December 31, 2020, the Company has sent 216 OCD reels in addition to helmets to some of the new and existing systems, since receiving the marketing approval in 2019.
• Cash and cash equivalents as of December 31, 2020 amounted to $ 17.1 million, compared to approximately $ 16 million at the end of the third quarter last year.
• Regarding the end of 2020, the company is debt free.
“We are very pleased that the company has achieved a strong end to 2020,” Noted Dr. Christopher von Jaco, president and CEO of Brainsway. “Our strong results reflect continued growing demand for the Deep TMS system in depression and OCD. We believe that even within the epidemic – and in a sense, because of the increased focus on mental health it has created – approval of our patented technology in a variety of indications continues to make a significant difference. While we continue to increase adoption across the US. We are excited about the opportunity to leverage this momentum in 2021. “
Financial forecast
While Brainsway does not routinely provide a quarterly financial forecast, given the exceptional circumstances caused by the Corona plague, the company believes it is important that investors and analysts have an understanding of the current state of the company’s business in this evolving environment. Therefore, Brainsway provided these preliminary and uncontrolled results. Actual results may change materially from forecasts as a result of developments or additional information that may arise between the present and the date on which the financial results are signed for the fourth quarter of 2020. These preliminary results should not be seen as a substitute for the Company’s audited financial statements.
For the full report